← Zurück zu Insidertransaktionen
Cameron Turtle
Gemeldet als: Turtle Cameron
Insider · Chief Executive Officer / Director
Käufe
0
0 USD
Verkäufe
15
4.122.220 USD
Unternehmen
1
mit gemeldeten Geschäften
Letzte Aktivität
01.10.2026
15 Transaktionen gesamt
| Datum | Unternehmen | Position | Art | Volumen | Preis | Stückzahl | Seit Meldung |
|---|---|---|---|---|---|---|---|
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 9.391,00 USD | 93,91 USD | 100 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 465.916,30 USD | 93,37 USD | 4.990 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 368.224,59 USD | 92,31 USD | 3.989 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 241.350,62 USD | 91,49 USD | 2.638 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 241.738,30 USD | 90,10 USD | 2.683 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 53.484,00 USD | 89,14 USD | 600 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 35.628,00 USD | 89,07 USD | 400 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 325.822,00 USD | 88,06 USD | 3.700 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 732.060,00 USD | 87,15 USD | 8.400 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 215.900,00 USD | 86,36 USD | 2.500 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.559,36 USD | 97,46 USD | 16 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 134.773,44 USD | 96,82 USD | 1.392 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 540.565,55 USD | 95,93 USD | 5.635 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 680.630,70 USD | 95,10 USD | 7.157 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 75.176,00 USD | 93,97 USD | 800 | – |
Alle von „Turtle Cameron" gemeldeten Eigengeschäfte (Directors' Dealings) gemäß Art. 19 MAR bzw. den jeweiligen nationalen Pflichtmeldungen. Gleiche Personen können unter abweichenden Schreibweisen mehrfach geführt sein. „Seit Meldung" vergleicht den aktuellen Kurs (deutsche Handelsplätze, EUR) mit dem gemeldeten EUR-Preis der Transaktion — Meldungen in anderen Währungen bleiben ohne Angabe. Details in der Methodik.